Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study-Reference-Cited by-同舟云学术

Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study

Published:2018-08-08 Issue:1 Volume:16 Page:
ISSN:1477-7819
Container-title:World Journal of Surgical Oncology
language:en
Short-container-title:World J Surg Onc

Author:

Urakawa Hiroshi^ORCID,Yonemoto Tsukasa,Matsumoto Seiichi,Takagi Tatsuya,Asanuma Kunihiro,Watanuki Munenori,Takemoto Akira,Naka Norifumi,Matsumoto Yoshihiro,Kawai Akira,Kunisada Toshiyuki,Kubo Tadahiko,Emori Makoto,Hiraga Hiroaki,Hatano Hiroshi,Tsukushi Satoshi,Nishida Yoshihiro,Akisue Toshihiro,Morii Takeshi,Takahashi Mitsuru,Nagano Akihito,Yoshikawa Hideki,Sato Kenji,Kawano Masanori,Hiraoka Koji,Tanaka Kazuhiro,Iwamoto Yukihide,Ozaki Toshifumi

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1186/s12957-018-1459-6.pdf

Reference25 articles.

1. Fletcher CDM. WHO classification of tumours of soft tissue and bone. 4th ed. Lyon: IARC Press; 2013.

2. Futamura N, Urakawa H, Tsukushi S, Arai E, Kozawa E, Ishiguro N, Nishida Y. Giant cell tumor of bone arising in long bones possibly originates from the metaphyseal region. Oncol Lett. 2016;11:2629–34.

3. Balke M, Schremper L, Gebert C, Ahrens H, Streitbuerger A, Koehler G, Hardes J, Gosheger G. Giant cell tumor of bone: treatment and outcome of 214 cases. J Cancer Res Clin Oncol. 2008;134:969–78.

4. Gaston CL, Bhumbra R, Watanuki M, Abudu AT, Carter SR, Jeys LM, Tillman RM, Grimer RJ. Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone? J Bone Joint Surg Br. 2011;93:1665–9.

5. van der Heijden L, van der Geest IC, Schreuder HW, van de Sande MA, Dijkstra PD. Liquid nitrogen or phenolization for giant cell tumor of bone?: a comparative cohort study of various standard treatments at two tertiary referral centers. J Bone Joint Surg Am. 2014;96:e35.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The diagnostic and prognostic value of tartrate-resistant acid phosphatase isoform 5b for giant cell tumor of bone;International Journal of Clinical Oncology;2024-07-12

2. Giant cell tumor of bone and secondary osteoarthritis;Heliyon;2024-05

3. The Effectiveness of Denosumab in Middle Eastern Patients With Giant Cell Tumor of the Bone: A Single-Center, Retrospective Study;Cureus;2024-04-15

4. Denosumab in Giant Cell Rich Tumors of Bone: An Open-Label Multicenter Phase II Study;The Oncologist;2023-07-14

5. Denosumab for giant cell tumors of bone from 2010 to 2022: a bibliometric analysis;Clinical and Experimental Medicine;2023-04-27